Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on
May 19, 2026
Category: Pakistan
Telefónica Germany Migrates 4G/5G Voice Services of First 100K Customers to Mavenir Cloud-Native IMS Technology
Milestone Move to IMS on AWS Achieved as Operator Transitions Fixed and Mobile Subscriber Base
May 18, 2026
CGTN: Head-of-state diplomacy anchors growing China-Russia partnership
Ahead of Russian President Vladimir Putin’s visit to China from May 19 to 20, CGTN
May 18, 2026
Quest Software Extends Data and AI Leadership with Quest Data Modeler and Quest Data Intelligence, Enhancing its Trusted Data Management Platform
New capabilities deliver cloud-native modeling, AI-powered policy management, and an expanded library of QuestAI assistants,
May 13, 2026
Green Building Initiative Announces Departure of CEO Vicki Worden
Vicki Worden, CAE, led GBI to achieve tremendous growth during her 11-year tenure; The Honorable
May 13, 2026
MagtiCom Selects Mavenir for Next-Generation Small Cell Technology Roll-Out Across Georgia
Mavenir Chosen as Strategic Small Cell Partner Following Successful Trial RICHARDSON, Texas, May 11, 2026
May 11, 2026